Ein Arzt berät einen Patienten (Symbolbild).
Mittwoch, 02.08.2017 12:50 von | Aufrufe: 331

Lifshitz & Miller LLP Announces Investigation of EZCORP, Inc., Flowserve Corporation, Halliburton Company, NCI, Inc., Parkway, Inc., United Therapeutics Corporation and ViewRay, Inc.

Ein Arzt berät einen Patienten (Symbolbild). © TommL / Vetta / Getty Images https://www.gettyimages.de/

PR Newswire

NEW YORK, Aug. 2, 2017 /PRNewswire/ --

EZCORP, Inc. (EZPW)

Lifshitz & Miller announces investigation on behalf of EZPW investors concerning whether EZPW issued false and misleading statements about its internal controls over financial reporting.

If you are an EZPW investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Flowserve Corporation (FLS)

Lifshitz & Miller announces investigation on behalf of FLS investors concerning whether FLS issued misleading financial statements from 2013 through the first quarter of 2017 involving certain inventory and accounts receivable balances.

If you are an FLS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.


ARIVA.DE Börsen-Geflüster

Kurse

9,20
-0,54%
Ezcorp Inc. Chart
46,20
0,00%
Flowserve Realtime-Chart
34,37
-2,27%
Halliburton Inc. Chart
-  
0,00%
NCI Chart
Parkway Properties Chart
255,10
0,00%
United Therapeutics Realtime-Chart
-  
0,00%
ViewRay Chart

Halliburton Company (HAL)

Lifshitz & Miller announces investigation on behalf of HAL investors concerning whether HAL violated the Foreign Corrupt Practices Act in connection with a $29.2 million fine by the U.S. Securities and Exchange Commission in July 2017.

If you are a HAL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516) 493-9780 or e-mail at info@jlclasslaw.com.

NCI, Inc. (NCIT)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of NCIT to H.I.G. Capital, LLC for $20.00 in cash for each share of NCIT owned.

If you are an NCIT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Parkway, Inc. (PKY)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of PKY to Canada Pension Plan Investment Board for $19.05 in cash and a one-time, special dividend of $4.00 to be paid prior to closing, for each share of PKY owned.

If you are a PKY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

United Therapeutics Corporation (UTHR)

Lifshitz & Miller announces investigation on behalf of UTHR investors concerning whether UTHR issued false and misleading statements about its contributions to patient-assistance charity groups and whether those contributions violated federal laws against kickbacks and false claims.

If you are a UTHR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ViewRay, Inc. (VRAY)

Lifshitz & Miller announces investigation on behalf of VRAY investors concerning whether VRAY issued false and misleading statements about purported connections VRAY has with Gottbetter associates, who allegedly have a track record of illegal gambling operations and ties to organized crime.

If you are a VRAY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING. © 2017 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com

View original content:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-announces-investigation-of-ezcorp-inc-flowserve-corporation-halliburton-company-nci-inc-parkway-inc-united-therapeutics-corporation-and-viewray-inc-300498207.html

SOURCE Lifshitz & Miller Law Firm

Werbung

Mehr Nachrichten zur United Therapeutics Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.